Abstract
Carcinoma associated fibroblasts (CAFs) play an important role in the growth of epithelial solid tumors. The origin of these tumor or CAFs has not been conclusively established. There is experimental evidence to suggest that part of the tumor or CAFs may arise from bone marrow derived mesenchymal stromal/stem cells or MSCs. It is well known that bone marrow derived MSCs can give rise to cells of different lineages: muscle, bone, fat, and cartilage. Based on recent work from our own laboratory and that of others, we now suggest that human BM-derived MSCs exposed to tumor-conditioned medium (TCM) over a prolonged period of time can give rise to cells that assume a CAF-like phenotype. Thus, MSCs may be a source of CAFs and can be used experimentally for modeling tumor-stroma interactions. Although the importance of the dialog between cancer cells and other components of the tumor milieu has been increasingly appreciated, it is as yet unclear whether the stromal cells themselves harbor cancer promoting mutations or changes. Activated stromal cells have been shown to promote tumor growth and metastasis in experimental models and we speculate on the possibility of increased activation of bone marrow derived MSCs by higher levels of chemokines under certain physiological situations and how this may impact tumor growth.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Albain KS, Unger JM, Crowley JJ, Coltman CA Jr, Hershman DL (2009) Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group. J Natl Cancer Inst 101(14):984–992
Alexe G, Dalgin GS, Scanfeld D et al (2007) High expression of lymphocyte-associated genes in node-negative HER2+ breast cancers correlates with lower recurrence rates. Can Research 67:10669–10676
Allinen M, Beroukhim R et al (2004) Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 6(1):17–32
Amend K, Hicks D, Ambrosone, CB (2006) Breast cancer in African-American women: differences in tumor biology from European American women. Cancer Res 66:8327–8330
Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet 357:539–545
Bissell MJ, Radisky D. (2001) Putting tumors in context. Nature Rev Cancer 1:46–54
Campbell I, Polyak K, Haviv I (2009) Clonal mutations in the cancer associated fibroblasts: the case against genetic coevolution. Cancer Res 69:6765–6769
Chaffer CL, Brennan JP, Slavin JL et al (2006) Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: role of fibroblast growth factor receptor-2. Cancer Res 66:11271–11278
Chang HY, Nuyten DS, Sneddon JB et al (2005) Robustness scalability and integration of a wound response gene expression signature in predicting breast cancer survival. Proc Natl Acad Sci U S A 102(10): 3738–3743
Direkze NC, Hodivala-Dilke K, Jeffery R et al (2004) Bone marrow contribution to tumor-associated myofibroblasts and fibroblasts. Cancer Res 64:8492–8495
Dudley AC, Shih SC, Cliffe AR et al (2008) Attenuated p53 activation in tumor-associated stromal cells accompanies decreased sensitivity to etoposide and vincristine. Br J Cancer 99:118–125
Dvorak HF (1986) Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 315:1650–1659
Eng C, Leone G, Orloff MS, Ostrowski MC (2009) Genomic alterations in tumor stroma. Cancer Res 69:6759–6764
Finak G, Bertos N, Pepin F et al (2008) Stromal gene expression predicts clinical outcome in breast cancer. Nat Med 14:518–527
Fox J M, Chamberlain G, Ashton BA, Middleton J (2007) Recent advances into the understanding of mesenchymal stem cell trafficking. Br J Haematol 137:491–502
Fukuma N, Akimitsu N, Hamamoto H, Kusuhara H, Sugiyama Y, Sekimizu K (2003) A role of the Duffy antigen for the maintenance of plasma chemokine concentrations. Biochem Biophys Res Commun 303:137–139
Guo X, Oshima H, Kitmura T et al (2008) Stromal fibroblasts activated by tumor cells promote angiogenesis in mouse gastric cancer. J Biol Chem 283:19864–19871
Hawsawi NM, Ghebeh H, Hendrayani SF et al (2008) Breast carcinoma-associated fibroblasts and their counterparts display neoplastic-specific changes. Cancer Res 68:2717–2725
Hu M, Polyak K (2008) Molecular characterisation of the tumour microenvironment in breast cancer. Eur J Cancer 44(18):2760–2765
Hung SC, Deng WP, Yang WK et al (2005) Mesenchymal stem cell targeting of microscopic tumors and tumor stroma development monitored by noninvasive in vivo positron emission tomography imaging. Clin Cancer Res 11:7749–7756
Iwamoto S, Mihara K, Dowining JR, Pui C-H, Campana D (2007) Mesenchymal cells regulate the response of acute lymphoblastic leukemia to asparaginase. J Clin Invest 117:1049–1057
Jodele S, Chantrain CF, Blavier L, Lutzko C, Crooks GM et al (2005) The contribution of bone marrow-derived cells to the tumor vasculature in neuroblastoma is matrix metalloproteinase-9 dependent. Cancer Res 65:3200–3208
Karnoub AE, Dash AB, Vo AP et al (2007) Mesenchymal stem cells within tumor stroma promote breast cancer metastasis. Nature 449:557–563
Koukourakis MI, Giatromanolaki A, Harris AL et al (2006) Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumor-associated stroma. Cancer Res 66:632–637
Koyama H, Kobayashi N, Harada M, Takeoka M, Kawai Y et al (2008) Significance of tumor-associated stroma in promotion of intratumoral lymphangiogenesis: pivotal role of a hyaluronan-rich tumor microenvironment. Am J Pathol 172:179–193
Kroemer G, Pouyssegur J (2008) Tumor cell metabolism: cancer’s Achilles’ heel. Cancer Cell 13:472–482
Lee JS, Frevert CW, Wurfel MM et al (2003) Duffy antigen facilitates movement of chemokine across the endothelium in vitro and promotes neutrophil transmigration in vitro and in vivo. J Immunol 170(10):5244–5251
Lentsch AB (2002) The Duffy antigen/receptor for chemokines (DARC) and prostate cancer. A role as clear as black and white? The FASEB Journal 16:1093–1095
Liu XH, Hadley TJ, Xu L, Peiper SC, Ray PE (1999) Up-regulation of Duffy antigen receptor expression in children with renal disease. Kidney Int 55(4):1491–1500
Mantovani A, Schioppa T, Porta C, Allavena P, Sica A (2006) Role of tumor-associated macrophages in tumor progression and invasion. Cancer Metastasis Rev 25:315–322
Martin DN, Boersma BJ et al (2009). Differences in the tumor microenvironment between African-American and European-American breast cancer patients. PloS One 4:1–14
Mayr FB, Spiel AO, Leitner JM, Firbas C, Kliegel T, Jilma B (2007) Ethnic differences in plasma levels of interleukin-8 (IL-8) and granulocyte colony stimulating factor (G-CSF). Transl Res 149(1):10–14
Mishra PJ, Mishra PJ, Humeniuk R et al (2008) Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells. Cancer Res 68:4331–4339
Nakamizo A, Marini F, Amano T et al (2005) Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res 65:3307–3318
Ogawa M, LaRue AC, Drake CJ (2006) Hematopoietic origin of fibroblasts/myofibroblasts: its pathophysiologic implications. Blood 108:2893–2896
Orimo A, Gupta PB, Sgroi DC et al (2005) Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121:335–348
Patocs A, Zhang L, Xu Y et al (2007) Breast-cancer stromal cells with TP53 mutations and nodal metastases. N Engl J Med 357:2543–2551
Picinich SC, Mishra PJ, Mishra PJ, Glod J, Banerjee D (2007) The therapeutic potential of mesenchymal stem cells. Expert Opin Biol Ther 7:965–973
Pittenger MF, Mackay AM, Beck SC et al (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284:143–147
Pruenster M, Mudde L, Bombosi P et al (2009) The Duffy antigen receptor for chemokines transports chemokines and supports their promigratory activity. Nat Immunol 10:101–108
Radisky DC (2005) Epithelial-mesenchymal transition. J Cell Sci 118:4325–4326
Ries L, Eisner M, Kosary M (2002) SEER Cancer Statistics Review, 1973–1999. National Cancer Institute, Bethesda, MD
Salomon AV, Thiery JP. (2003) Host microenvironment in breast cancer development Epithelial–mesenchymal transition in breast cancer development. Breast Cancer Res 5:101–106
Samudio I, Fiegl M, McQueen T et al (2008) The Warburg effect in leukemia-stroma cocultures is mediated by mitochondrial uncoupling associated with uncoupling protein-2 activation. Cancer Res 68:5198–5205
Shen H, Schuster R, Stringer KF, Waltz SE, Lentsch AB (2006) The Duffy antigen/receptor for chemokines (DARC) regulates prostate tumor growth. FASEB J 20:59–64
Shinagawa K, Kiatadai Y, Ohara E et al (2009) Mesenchymal stem cells migrate to tumor stroma and enhance tumor growth in an orthotopic nude mouse model of colon cancer. Abstract 3156. p314 Proc of 100th Annual Meeting AACR, Denver,CO, 18–22 April 2009
Sorlie T, Perou CM, Tibshirani R et al (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 98:10869–10874
Spaeth EL, Dembinski JL, Kate Sasser A et al (2009) Mesenchymals stem cell transition to tumor associated fibroblasts contributes to fibrovascular network expansion and tumor progression. PloS One 4:1–11
Studeny M, Marini FC, Champlin RE et al (2002) Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. Cancer Res 62:3603–3608
Studeny M, Marini FC, Dembinski JL et al (2004) Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. J Natl Cancer Inst 96:1593–1603
Tournamille C, Colin Y, Cartron JP, Le Van Kim C (1995) Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals. Nat Genet 10:224–228
Tsujino T, Seshimo I, Yamamoto H, Ngan CY, Ezumi K et al (2007) Stromal myofibroblasts predict disease recurrence for colorectal cancer. Clin Cancer Res 13:2082–2090
Udagawa T, Puder M, Wood M, Schaefer BC, D’Amato RJ (2006) Analysis of tumor-associated stromal cells using SCID GFP transgenic mice: contribution of local and bone marrow-derived host cells. FASEB J 20:95–102
van de Vijver MJ, He YD, van’t Veer LJ et al (2002) Gene expression profiling predicts clinical outcome of breast cancer. N Engl J Med 347(25):1999–2009
Wadhwa M, Seghatchian MJ, Dilger P, Contreras M, Thorpe R (2000) Cytokine accumulation in stored red cell concentrates: effect of buffy-coat removal and leucoreduction. Transfus Sci 23(1):7–16
Wang Y, Klijn JG, Zhang Y et al (2005) Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365:671–679
Wang J, Ou ZL, Hou YF, Luo JM, Shen ZZ, Ding J, Shao ZM (2006) Enhanced expression of Duffy antigen receptor for chemokines by breast cancer cells attenuates growth and metastasis potential. Oncogene 25:7201–7211
Weber F, Xu Y, Zhang L, Patocs A, Shen L, Platzer P, Eng C (2007) Microenvironmental genomic alterations and clinicopathological behavior in head and neck squamous cell carcinoma. JAMA 297:187–195
Worthley DL, Ruszkiewicz A, Davies R et al (2009) Human Gastrointestinal neoplasia associated myofibroblasts can develop from bone marrow derived cells following allogeneic stem cell transplantation. Stem Cells 27:1463–1468
Yazhou C, Wenlv S, Weidong Z, Licun W (2004) Clinicopathological significance of stromal myofibroblasts in invasive ductal carcinoma of the breast. Tumor Biol 25:290–295
Zhang Y, Daquinag A, Traktuev DO et al (2009) White adipose tissue cells are recruited by experimental tumors and promote cancer progression in mouse models. Cancer Res 69:5259–5265
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Mishra, P.J., Banerjee, D. (2010). Bone Marrow Derived Mesenchymal Stem/Stromal Cells and Tumor Growth. In: Bagley, R. (eds) The Tumor Microenvironment. Cancer Drug Discovery and Development. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-6615-5_13
Download citation
DOI: https://doi.org/10.1007/978-1-4419-6615-5_13
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-6614-8
Online ISBN: 978-1-4419-6615-5
eBook Packages: MedicineMedicine (R0)